Source: RGD

Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6571
Gene Symbol: SLC18A2
SLC18A2
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease 		0.600 Biomarker RGD Protective effect of Zhen-Wu-Tang (ZWT) through keeping DA stable and VMAT 2/DAT mRNA in balance in rats with striatal lesions induced by MPTP. 21291984

2011
Entrez Id: 6571
Gene Symbol: SLC18A2
SLC18A2
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease 		0.600 Biomarker RGD Vesicular monoamine transporter-2 and aromatic L-amino acid decarboxylase gene therapy prevents development of motor complications in parkinsonian rats after chronic intermittent L-3,4-dihydroxyphenylalanine administration. 16269145

2006
Entrez Id: 6571
Gene Symbol: SLC18A2
SLC18A2
CUI: C0024408
Disease: Machado-Joseph Disease
Machado-Joseph Disease 		0.210 Biomarker RGD Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease. 18385100

2008
Entrez Id: 6571
Gene Symbol: SLC18A2
SLC18A2
CUI: C0011854
Disease: Diabetes Mellitus, Insulin-Dependent
Diabetes Mellitus, Insulin-Dependent 		0.210 Biomarker RGD Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. 16710474

2006
Entrez Id: 6571
Gene Symbol: SLC18A2
SLC18A2
CUI: C0235032
Disease: Neurotoxicity Syndromes
Neurotoxicity Syndromes 		0.200 Biomarker RGD Enzymatic-nonenzymatic cellular antioxidant defense systems response and immunohistochemical detection of MDMA, VMAT2, HSP70, and apoptosis as biomarkers for MDMA (Ecstasy) neurotoxicity. 19798748

2010
Entrez Id: 6571
Gene Symbol: SLC18A2
SLC18A2
CUI: C0236969
Disease: Substance-Related Disorders
Substance-Related Disorders 		0.200 Biomarker RGD A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. 17683483

2007